Takeover Offer from USA for Evotec
Halozyme intends to expand its drug discovery and development portfolio through the acquisition of Evotec. Halozyme intends to acquire all shares of Evotec at a price of EUR 11 per share. “The combination of Halozyme and Evotec would diversify and extend …